Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dobrin Nedelkov

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Diabetes Care|October 25, 2024
Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes StudyJuraj Koska, Yueming Hu, Jeremy Furtado, et al.
Journal of Lipid Research|March 6, 2016
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetesJuraj Koska, Hussein Yassine, Olgica Trenchevska, et al.
Plos One|January 22, 2015
Serum amyloid a truncations in type 2 diabetes mellitusHussein N Yassine, Olgica Trenchevska, Huijuan He, et al.
Alzheimer'S Research & Therapy|May 23, 2023
An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 alleleCristiana J Meuret, Yueming Hu, Sabrina Smadi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkersDobrin Nedelkov, Zoe E Tsokolas, Matheus Scarpatto Rodrigues, et al.
Alzheimer'S Research & Therapy|July 9, 2025
Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkersDobrin Nedelkov, Zoe E Tsokolas, Matheus Scarpatto Rodrigues, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2019
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) ReceptorsNatalie C Kegulian, Bastian Ramms, Steven Horton, et al.
Plos One|November 27, 2013
Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1Eric E Niederkofler, David A Phillips, Bryan Krastins, et al.
Plos One|December 4, 2015
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma TriglyceridesHussein N Yassine, Olgica Trenchevska, Ambika Ramrakhiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Quantification of circulating <i>Mycobacterium tuberculosis</i> antigen peptides allows rapid diagnosis of active disease and treatment monitoringChang Liu, Zhen Zhao, Jia Fan, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Diabetes Care|October 25, 2024
Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes StudyJuraj Koska, Yueming Hu, Jeremy Furtado, et al.
Journal of Lipid Research|March 6, 2016
Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetesJuraj Koska, Hussein Yassine, Olgica Trenchevska, et al.
Plos One|January 22, 2015
Serum amyloid a truncations in type 2 diabetes mellitusHussein N Yassine, Olgica Trenchevska, Huijuan He, et al.
Alzheimer'S Research & Therapy|May 23, 2023
An association of CSF apolipoprotein E glycosylation and amyloid-beta 42 in individuals who carry the APOE4 alleleCristiana J Meuret, Yueming Hu, Sabrina Smadi, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkersDobrin Nedelkov, Zoe E Tsokolas, Matheus Scarpatto Rodrigues, et al.
Alzheimer'S Research & Therapy|July 9, 2025
Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer's disease biomarkersDobrin Nedelkov, Zoe E Tsokolas, Matheus Scarpatto Rodrigues, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 9, 2019
ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) ReceptorsNatalie C Kegulian, Bastian Ramms, Steven Horton, et al.
Plos One|November 27, 2013
Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1Eric E Niederkofler, David A Phillips, Bryan Krastins, et al.
Plos One|December 4, 2015
The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma TriglyceridesHussein N Yassine, Olgica Trenchevska, Ambika Ramrakhiani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2017
Quantification of circulating <i>Mycobacterium tuberculosis</i> antigen peptides allows rapid diagnosis of active disease and treatment monitoringChang Liu, Zhen Zhao, Jia Fan, et al.
Pageof 8